Carcinoma in situ of other parts of intestine
ICD-10 D01.49 is a billable code used to indicate a diagnosis of carcinoma in situ of other parts of intestine.
Carcinoma in situ (CIS) of the intestine refers to a localized cancer that has not invaded surrounding tissues. This condition is characterized by the presence of abnormal cells in the lining of the intestine, which have the potential to develop into invasive cancer if left untreated. The term 'other parts of intestine' encompasses areas such as the jejunum, ileum, and other segments not specifically classified under more common sites like the colon or rectum. Diagnosis typically involves endoscopic procedures, biopsies, and imaging studies to assess the extent of the disease. Surveillance protocols for patients diagnosed with CIS include regular endoscopic evaluations and imaging to monitor for progression to invasive cancer. The risk of progression varies based on factors such as the histological grade of the carcinoma, the presence of dysplasia, and patient-specific factors like age and comorbidities. Early detection and intervention are crucial in managing this condition effectively, as timely treatment can prevent the development of invasive cancer.
Detailed endoscopic reports, biopsy results, and follow-up plans.
Patients undergoing surveillance for CIS after initial diagnosis, management of dysplastic lesions.
Ensure clear documentation of the site and histological findings to support coding.
Comprehensive treatment plans, pathology reports, and imaging studies.
Patients receiving treatment for CIS, monitoring for progression to invasive cancer.
Documenting the rationale for treatment decisions and follow-up care is critical.
Used for surveillance in patients with carcinoma in situ.
Document findings, biopsies taken, and any interventions performed.
Gastroenterologists should ensure thorough documentation of the procedure and findings.
Carcinoma in situ is a localized cancer that has not invaded surrounding tissues, while invasive carcinoma has spread beyond the epithelial layer into surrounding tissues.
